The Study is an Observational Post-market Follow-up Program to Evaluate Long Term (5 Years) Safety of Mentor Breast Implants in Chinese Population
MNT202401: Post Market Clinical Follow up for Mentor Breast Implants
- Breast Augmentation
- Mammaplasty
At a glance
- Phase
- Phase not stated
- Study type
- Observational
- Sponsor
- Johnson & Johnson Medical (Shanghai) Ltd.
- Enrolment target
- 6,111
- Started
- 14 July 2024
- Main results due
- 30 June 2034
- Study sites
- 4
- Registry updated
- 28 September 2026
Can you take part?
- Ages 18 years to 100 years.
- Women only.
- You need the condition being studied — healthy volunteers are not accepted.
These are the headline rules only. Every study has a longer list, and whether you are eligible is decided by the research team at the site — never by this page.
Read the full eligibility criteria
Inclusion Criteria: 1. Women who have received Mentor breast implants per product instructions; 2. Participants must possess the ability to comprehend the study procedures, give consent for the use of their preoperative and surgical data, and agree to take part in postoperative follow-up assessments. Additionally, they should possess the necessary civil capacity, be capable of reading and writing, and willingly provide informed consent by signing the consent form. 3. Aged not less than 18 years at the time of implantation surgery (for products with registration license Guoxie Zhujin 20223130323, the participant's age should be not less than 22 years). Exclusion Criteria: * Not applicable
What this study is about
In the sponsor’s own words, from the registry.
The Mentor Post-Market Clinical Follow-Up Study is a multicenter observational study conducted in China. It aims to collect safety data on Mentor breast implants over a 5-year follow-up period in the Chinese population. In addition to safety data, the study will also gather information on postoperative pain and participant satisfaction levels. The objective is to explore customers' clinical experiences and use them as a reference for future product development. The study intends to enroll different number of participants for each license.
Study sites(4)
Sichuan Huamei Zixin Medical Aesthetic Hospital
Chengdu, China
Recruiting
Yunnan Huamei Meilai Cosmetology Hospital
Kunming, China
Recruiting
Shenzhen Yixing Medical Cosmetology Hospital
Shenzhen, China
Recruiting
Shenzhen Junke Medical Cosmetology Clinic
Shenzhen, China
Recruiting
Showing 4 of 4 sites. 4 of the 4 sites on this study are recruiting right now — a site can stop enrolling while the study as a whole is still open.
Source: ClinicalTrials.gov record NCT06510205. Trialion does not run this study, is not paid to refer anyone to it, and cannot enrol you. Eligibility is always decided by the research team at the site.
Not the right study?
Answer three questions and see the studies recruiting near you, in plain language.
Find a study for me